AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
United States
Los Angeles County-USC Medical Center, Los Angeles, California USC / Norris Comprehensive Cancer Center, Los Angeles, California Age range
18 Years and older
Last updated February 2026